Scope of Pharmacovigilance for Ayurvedic Drugs in Nepal: A Review

Authors

  • Ram Deo Pandit1 PG Scholar, Department of Dravyaguna, Rajiv Gandhi Government Post Graduate Ayurvedic College and Hospital (RGGPGAC&H), Paprola, Kangra, Himachal Pardesh, India Author
  • Ashwani Upadhyaya Faculty, Department of Dravyaguna, Rajiv Gandhi Government Post Graduate Ayurvedic College and Hospital (RGGPGAC&H), Paprola, Kangra, Himachal Pardesh, India Author
  • Navneet Sharma Faculty, Department of Dravyaguna, Rajiv Gandhi Government Post Graduate Ayurvedic College and Hospital (RGGPGAC&H), Paprola, Kangra, Himachal Pardesh, India Author
  • Chandni Gupta Faculty, Department of Dravyaguna, Rajiv Gandhi Government Post Graduate Ayurvedic College and Hospital (RGGPGAC&H), Paprola, Kangra, Himachal Pardesh, India Author
  • Ritika PG Scholar, Department of Dravyaguna, Rajiv Gandhi Government Post Graduate Ayurvedic College and Hospital (RGGPGAC&H), Paprola, Kangra, Himachal Pardesh, India Author

DOI:

https://doi.org/10.48165/

Keywords:

Adverse drug reactions (ADRs), Pharmacovigilance, Department of Drug Administration (DDA), International Drug Monitoring (IDM)

Abstract

Ayurveda along with complementary and alternative medicine (CAM) systems  have their own principles, have their own pharmacopeia, but are practiced as  over the counter drugs without an authentic prescription. Government of Nepal  nominated Department of Drug Administration (DDA) in October 2004 as the  focal point (National Pharmacovigilance Centre) to liaison with WHO  collaborating centre for International Drug Monitoring (IDM), Sweden and  started collecting adverse drug reactions (Nepal became a WHO program  member in July 2006). Nepal joined the international pharmacovigilance  program as a full member in 2007. This study is to reflect the present status of  pharmacovigilance in Nepal and put light on scope of pharmacovigilance on  drugs of Ayurveda and other complementary alternative systems in Nepal. For  which review and analysis of concerned published literatures in print form and  in online database. At present; 12 regional pharmacovigilance centers are there  in Nepal. Currently, the clear pattern and scope of adverse drug reactions  (ADRs) in Nepal remains unexplored. For Ayurveda drugs the concept of  pharmacovigilance is not yet formally introduced in Nepal. No policy has been  formulated for the same. The conventional belief that Ayurveda drugs have no  ADRs should be transformed. 

Downloads

Download data is not yet available.

References

Ajanal, M., Nayak, S., Prasad, B. S., & Kadam, A. Adverse drug reaction and concepts of drug safety in Ayurveda: An overview. Journal of young pharmacists:

JYP, 5(4), 116–120. https://doi.org/10.1016/j.jyp.2013.10.001

Mishra P, Upadhyay P, Rawat R, Ashraf D T, Dev K, Chauhan N, A Review on Pharmacovigilance Process In India, Asian Journal of Pharmaceutical Research and Development. 2020; 8(3):190-195. DOI: http://dx.doi.org/10.22270/ajprd.v8i3.735

Mishra P, Upadhyay P, Rawat R, Ashraf D T, Dev K, Chauhan N, A Review on Pharmacovigilance Process In India, Asian Journal of Pharmaceutical Research and Development. 2020; 8(3):190-195. DOI: http://dx.doi.org/10.22270/ajprd.v8i3.735

Mishra P, Upadhyay P, Rawat R, Ashraf D T, Dev K, Chauhan N, A Review on Pharmacovigilance Process In India, Asian Journal of Pharmaceutical Research and Development. 2020; 8(3):190-195. DOI: http://dx.doi.org/10.22270/ajprd.v8i3.735

The importance of pharmacovigilance: Safety monitoring of medicinal products. [Internet]. Geneva: World Health Organization: 2002. Available at http://www.who.int/medicinedocs/collect/medicinedocs/p

df/s4893e/s4893e.pdf (Accessed 1/12/2021)

Jha N, Shankar PR, Bajracharya O, Gurung SB, Singh KK. Adverse drug reaction reporting in a pharmacovigilance centre of Nepal. AMJ 2012, 5, 5, 268- 271. http//dx.doi.org/10.4066/AMJ.2012.1142

Jha N, Shankar PR, Bajracharya O, Gurung SB, Singh KK. Adverse drug reaction reporting in a pharmacovigilance centre of Nepal. AMJ 2012, 5, 5, 268- 271. http//dx.doi.org/10.4066/AMJ.2012.1142

Jha N, Shankar PR, Bajracharya O, Gurung SB, Singh KK. Adverse drug reaction reporting in a pharmacovigilance centre of Nepal. AMJ 2012, 5, 5, 268- 271. http//dx.doi.org/10.4066/AMJ.2012.1142

Jha N, Shankar PR, Bajracharya O, Gurung SB, Singh KK. Adverse drug reaction reporting in a pharmacovigilance centre of Nepal. AMJ 2012, 5, 5, 268- 271. http//dx.doi.org/10.4066/AMJ.2012.1142

Olsson S. The role of the WHO programme on International Drug Monitoring in coordinating worldwide drug safety efforts. Drug Saf. 1998;19(1):1–10. doi:10.2165/00002018-199819010-00001

Santosh KC, Tragulpiankit P, Gorsanan S, Edwards IR. Attitudes among healthcare professionals to the reporting of adverse drug reactions in Nepal. BMC PharmacolToxicol. 2013; 14:16. doi:10.1186/2050-6511- 14-16

Ajanal, M., Nayak, S., Prasad, B. S., & Kadam, A. Adverse drug reaction and concepts of drug safety in Ayurveda: An overview. Journal of young pharmacists: JYP, 5(4), 116–120. https://doi.org/10.1016/j.jyp.2013.10.001

Ajanal, M., Nayak, S., Prasad, B. S., & Kadam, A. Adverse drug reaction and concepts of drug safety in Ayurveda: An overview. Journal of young pharmacists: JYP, 5(4), 116–120. https://doi.org/10.1016/j.jyp.2013.10.001

https://www.dda.gov.np/content/pharmacovigilance 15. Jha N, Shankar PR, Bajracharya O, Gurung SB, Singh KK. Adverse drug reaction reporting in a pharmacovigilance centre of Nepal. AMJ 2012, 5, 5, 268- 271. http//dx.doi.org/10.4066/AMJ.2012.1142

https://www.dda.gov.np/content/pharmacovigilance 17. https://www.dda.gov.np/content/pharmacovigilance 18. Shrestha S, Shrestha R, Abidi A, Upadhyay A, Khanal T,

Adhikari B, Ghimire BR. Workshop on Adverse Drug Reaction Reporting, Pharmacovigilance and Its Implementation in Cancer Hospital in Nepal: An Event Report. Adv Med Educ Pract. 2020;11:9-14 https://doi.org/10.2147/AMEP.S225208

https://www.dda.gov.np/content/pharmacovigilance 20. Mishra P, Upadhyay P, Rawat R, Ashraf D T, Dev K, Chauhan N, A Review on Pharmacovigilance Process In India, Asian Journal of Pharmaceutical Research and Development. 2020; 8(3):190-195. DOI: http://dx.doi.org/10.22270/ajprd.v8i3.735

Baghel M. The National Pharmacovigilance Program for Ayurveda, Siddha and Unani Drugs: Current status. International journal of Ayurveda research, 2010.1(4), 197–198. https://doi.org/10.4103/0974-7788.76779

Baghel M. The National Pharmacovigilance Program for Ayurveda, Siddha and Unani Drugs: Current status. International journal of Ayurveda research, 2010 1(4), 197–198. https://doi.org/10.4103/0974-7788.76779

Downloads

Published

2024-04-13

How to Cite

Pandit1, R.D., Upadhyaya, A., Sharma, N., Gupta, C., & Ritika. (2024). Scope of Pharmacovigilance for Ayurvedic Drugs in Nepal: A Review. International Research Journal of Ayurveda and Yoga, 5(3), 86–93. https://doi.org/10.48165/